Skip to main navigation Skip to search Skip to main content

A Randomized, Open-Label, Comparative Evaluation of Conversion From Calcineurin Inhibitors to Sirolimus Versus Continued Use of Calcineurin Inhibitors in Renal Allograft Recipients

Project: Research

Project Details

StatusFinished
Effective start/end date02/1/03 → 07/30/09

Funding

  • Wyeth Pharmaceuticals: $52,282.77